October 7, 2024
July 21, 2021
Gedeon Richter Plc. (‘Richter’) announces that the European Commission (‘EC’) has granted approval for the marketing authorisation of
April 30, 2021
Myovant Sciences (NYSE:MYOV), a healthcare company focused on developing innovative treatments for women’s health and prostate cancer
